Funding information VENI Grant, Grant number: 016.095.060 47,XXY (KS) occurs in 1:650 male births, though less than 25% are ever identified. We assessed stability of neurocognitive features across diverse populations and quantified factors mediating outcome. Forty-four boys from the Netherlands (NL) and 54 boys from the United States (US) participated. The Wechsler Intelligence Scales assessed intellectual functioning; the ANT program evaluated cognitive function; and the CBCL assessed behavioral functioning. ANOVA was used for group comparisons. Hierarchical regressions assessed variance explained by each independent variable: parental education, timing of diagnosis, testosterone, age, and nationality. Parental education, timing of diagnosis, and hormonal treatment all played an important role in neurocognitive performance. The observed higher IQ and better attention regulation in the US group as compared to the NL group was observed with decreased levels of behavioral problems in the US group. Cognitive measures that were different between the NL and US groups, i.e., attention regulation and IQ scores, were also significantly influenced by external factors including timing of diagnosis, testosterone treatment, and parental education. On the ANT, a cognitive phenotype of 47,XXY was observed, with similar scores on 9 out of the 10 ANT subtests for the NL and US groups. This study lays additional features to the foundation for an algorithm linking external variables to outcome on various neurodevelopmental measures.
63% (Lee et al., 2011; Tartaglia, Ayari, Hutaff-Lee, & Boada, 2012) .
Wide divergence is also observed in the intelligence profile of boys with 47,XXY, with the majority of boys exhibiting intact cognitive profiles and IQs within the normal range (and some in the gifted range), and few with mild intellectual disabilities (Leggett et al., 2010; Simpson et al., 2003) . A host of genetic and environmental factors are influential in this phenotypic variability, although the relative contributions of these multiple factors remains unclear. Genetic influences include skewed X inactivation (Iitsuka et al., 2001) , parental origin of the additive X chromosome (Bruining et al., 2010) , mosaicism (Mohd & Jalaludin, 2016) , and a positive family history of learning disabilities , SamangoSprouse et al., 2014 . External factors include prenatal versus postnatal diagnosis (Girardin et al., 2009; Ross et al., 2012; Simpson et al., 2003) , ancillary services received, and androgen replacement therapy implemented during infancy and/or at the onset of puberty (Mehta & Paduch, 2012; Patwardhan, Eliez, Bender, Linden, & Reiss, 2000; Ross et al., 2005; SamangoSprouse et al., 2015) .
Boys who are prenatally diagnosed are more likely to receive earlier ancillary services and/or hormonal treatment when there is a greater degree of neural plasticity, and positive response to treatment (Ross et al., 2017) . Linden and Bender (2002) , for instance, demonstrated a decrease in neurodevelopmental problems, particularly learning disabilities, in prenatally diagnosed as compared to postnatally diagnosed children with X and Y Chromosomal disorders.
In this study, we investigated two populations of boys with 47, XXY: one in the United States (US) and one in the Netherlands (NL). We examined the neurocognitive and behavioral profiles of these 47,XXY populations and assessed variability within them. We investigated how stable or "penetrant" the phenotype of 47,XXY is, and aimed to identify external factors that contribute to the observed phenotypic variability.
These findings have theoretical relevance, in terms of both vulnerability mechanisms as well as clinical treatment in 47,XXY. A predictive algorithm detailing the most prominent contributors and their respective effect size on presentation could be very valuable in providing more personalized and targeted treatment options given the wide range of developmental function in 47,XXY.
| MATERIALS AND METHODS

| Participants
In the NL, 44 boys with 47,XXY participated as part of a large study on cognition and behavioral constructs in this disorder. The participants ranged from 8 to 18 years (mean 11.8 ± 3.5). The subjects included children with a prenatal diagnosis, children recruited through support groups, and those referred due to known developmental deficits. In the US, 54 boys with 47,XXY participated with ages ranging from 8 to 18 years (mean 11.5 ± 2.6). The group of US boys with 47,XXY were recruited through a diagnostic center as part of their routine neurodevelopmental care. NL and US ages were not significantly different (p =.61 (Wechsler, 1991) , and the Wechsler Intelligence Scales for Adults (WAIS) for study participants over 16 years of age (Wechsler, 2005) . As in the original versions, the Dutch versions have adequate reliability and validity. The WISC generates a verbal IQ (VIQ), and a performance IQ (PIQ) (M = 100, SD = 15) through 12 subtests. VIQ assesses verbal skills such as verbal reasoning and verbal comprehension. PIQ assesses various visual-spatial abilities and perceptional reasoning.
| Parental education
Parental education was assessed according to the criteria of Hollingshead, employing a scale from 0 (no formal education) to 7 (graduate/ professional training) (Hollingshead, 1975) . Other scores of this scale include: 1 (less than seventh grade), 2 (junior high school), 3 (partial high school), 4 (high school graduate), 5 (partial college or specialized training), and 6 (standard college/university graduation) (Hollingshead, 1975) . Level of education was averaged over both parents.
| Cognitive test battery
| Amsterdam Neuropsychological Tasks
The Amsterdam Neuropsychological Tasks (ANT) program (de Sonneville, 1999) has proven to be helpful in defining neurocognitive profiles in diverse populations (Rommelse et al., 2008; Serra et al., 2003) and several studies have demonstrated satisfactory psychometric properties of the ANT (for a review see de Sonneville, 2005) .
Stimuli are presented on the computer screen and participants respond using a mouse. Each subtest is preceded by illustration trials and practice trials. The ANT generates norm scores based on nonlinear regression functions capturing the normative data in the age range of 4-66 years with total sample sizes varying between 2,500 and 6,000 subjects, depending on type of task. Higher (positive) Z scores represent more impaired performance. A pilot study was performed in the US and showed that 15 typically developing children (aged between 8 and 18 years) had Z scores between Z − 0.5 and Z + 0.5 (i.e., well within the Dutch normal range).
Based on this pilot study we were confident in using the Dutch norm scores for the US sample. Supplementary Table S1 provides an explanation of all subtests on the ANT.
| Emotional/behavioral problems
The norm-referenced Child Behavior Checklist (CBCL) describes recent emotional and behavioral functioning in children 6-18 years of age (Achenbach & Edlebrock, 1991) 
| Statistical analyses
Group comparisons of IQ and age (US/NL) were analyzed using Analysis of Variance (ANOVA), as these variables were normally distributed. Group comparisons of CBCL scores, parental education, number of children with prenatal/postnatal diagnosis, number of testosterone treated/non-treated children, number of children starting testosterone treatment in infancy versus childhood/adolescence, and the ANT parameters were analyzed using non-parametric (MannWhitney) tests, since these variables were not normally distributed.
External factors, i.e., parental education, prenatal/postnatal diagnosis, and testosterone treatment (yes/no), were used to predict cognitive and behavioral scores using regression analyses, which do not require a normal distribution, in the US group and NL group, collapsed. Age was added to control for developmental effects. A hierarchical regression was used with age, parental education, pre/postnatal diagnosis, and testosterone treatment (yes/no) as predictors in the first box (stepwise selection). Country was added in the second box (remove selection) to test if, after explaining variance using parameters of interest in the first box, "country" was still a significant factor in explaining remaining variance (i.e., if it was required to improve the regression model).
Because the number of children starting testosterone treatment in infancy versus childhood/adolescence was only applicable for the US sample, separate regression analyses were performed for this specific subgroup to predict cognitive and behavioral scores, with early versus late testosterone treatment and age as predictors (stepwise selection).
Multicollinearity among predictors was also checked for in the regression analyses. For the group-wise (US/NL) nonparametric comparisons across multiple cognitive domains (ANT) and multiple behavioral domains (CBCL), the threshold for significance was set at p = .01 to correct for multiple comparisons. For other group comparisons that did not involve multiple comparisons, and for regression analyses, the threshold for significance was set at p = .05. 
| Testosterone treatment
Distribution of testosterone treated versus nontreated in the US and NL samples are presented in Table 1 . Of the NL children, 16.7% had received or were receiving testosterone treatment (vs. 83.3% nontreated children). Of the US children, 55.6% had received or were receiving testosterone treatment (vs. 44.4% non-treated). The group difference in ratio of testosterone treated and non-treated children was significant (z = −3.8, p < .001). 
| Group differences in intellectual and cognitive functioning
Incomplete data from two participants in the NL sample were removed. In the NL sample, average VIQ was 78.1 (± 13.7) and average PIQ was 85.1 (± 15.7). In the US sample, average VIQ was 109.3 (± 11.3) and average PIQ was 114.9 (± 12.1). Group differences in VIQ and PIQ were significant: F (1,94) = 148.8, p < 0.001 and F
(1,94) = 110.6, p < 0.001, respectively.
A summary of group differences in cognitive functioning as measured by the ANT is presented in Table 2 . First, when comparing the average Z scores across the US sample and NL sample, the majority of cognitive parameters did not show significant group differences.
However, as compared to the US sample, the NL sample showed more severe impairments in attention regulation as expressed in stability of tempo (z = −3.3, p < 0.001).
Next, in order to assess developmental risk within both samples, we calculated the percentage of children in the "intact/borderline" range (Z < 2.0, i.e., below 98th percentile) and "significantly impaired" range (Z > 2.0, i.e., above 98th percentile) for each cognitive domain.
Performance was categorized on an individual level for each cognitive domain (Table 3) .
We also calculated the percentage of children (who completed at least 8 out of 10 tests on the ANT) showing various levels of severity in their cognitive phenotype, as expressed by the number of cognitive domains that were affected (Figure 2 ). In the US group, a majority of the children (77.8%) had 0-3 cognitive domains affected, which suggests less effect of the additive X. There was only one US participant (2.2%) in the 7-10 cognitive domains affected range. In the NL group, the children were more evenly distributed across the range of cognitive domains affected. Of the NL children, 59.5% fell within the 0-3 cognitive domains affected, while 16.2% fell in the 7-10 cognitive domains affected range.
However, χ 2 analysis showed no significant differences in distribution between the US and NL groups (z = −1.51, p = .13). Also, the average percentage of affected domains (31.9% (± 23.9) for the NL sample and 28.4% (± 20.3) for the US sample) was not different across groups, (z = −0.40, p = .68).
| Group differences in emotional/behavioral problems
Incomplete CBCL data from eight participants in the NL sample were removed. Average CBCL T-scores for Total Problems were significantly higher in the NL sample (63.9 ± 9.6) than the US sample (54.8 ± 11.6), z = −3.5, p < 0.001. Similarly, scores for Internalizing
Problems were significantly higher in the NL sample (63.4 ± 10.6) than the US sample (56.5 ± 11.7), z = −2.74, p = .006. Average T-scores for Externalizing Problems were 58.1 (±12.2) in the NL sample and 59.3 (± 11.7) in the US sample, which were not significantly different (z = −2.4, p = .015). See Table 4 . overview of all significant predictors of intellectual and cognitive functioning, see Table 5 .
Multicollinearity among predictors in the regression analyses revealed all variance inflation factor (VIF) values were approximately 1, demonstrating that these predictors (parental education levels, testosterone treatment, and time of diagnoses) are not intercorrelated.
Thus, parental education was not associated with testosterone treatment or time of diagnoses. predictor: testosterone treatment (t = −2.3, p = .022, β = −.25). The predictor "country," which was added in block two of the hierarchical regressions, did not significantly improve the models. Prenatal diagnosis was thus a significant predictor of lower levels of internalizing problems, and testosterone treatment was a significant predictor of externalizing problems (Table 5) .
| Behavioral functioning
With regard to the subgroups of testosterone-treated subjects (n = 42), some subjects began treatment in infancy (n = 16), while some subjects began treatment in childhood or adolescence (≥ age 6 years, n = 23). Therefore, within the testosterone treated sample, it was evaluated whether the variable "timing of treatment" (with the variable "age" added to control for maturational effects) predicted any of the cognitive and behavioral measures. The only cognitive/behavioral dimension that was significantly predicted by timing of treatment was
Inhibition, which showed a significant model (F (1,47) = 5.0, p = .03) explaining 9.6% of the variance. This included one predictor which was timing of treatment (t = 2.2, p = .03, β = .31). Thus, testosterone treatment beginning in infancy, rather than childhood/adolescence, was associated with better inhibitory control. No significant models were found for the other cognitive/behavioral measures.
| DISCUSSION
To our knowledge, this is the first international and collaborative investigation using IQ assessment, a computerized neuropsychological as seen by the similar group scores on 9 out of the 10 ANT subtests.
These findings are more robust given that the participants span two countries with diverse populations in terms of parental education, timing of diagnosis, treatment procedures, and interventional strategies. This study also provides an estimate of effect sizes on intellectual, cognitive, and behavioral outcome that has not been previously described.
Our findings are consistent with previous findings that have revealed boys with 47,XXY may exhibit deficits in executive functioning (Kompus et al., 2011; van Rijn & Swaab, 2015) . Executive functioning is governed by the frontal lobe, and boys with 47,XXY have abnormal structure and function of this area of the brain (van Rijn & Swaab, 2015) . Based on the findings in this study, it may be Conversely, a reactive and variable care plan is more common in postnatally diagnosed children, who often do not receive appropriate services before the onset of problems.
Recently, several published articles have demonstrated the positive effect of testosterone on behavioral function and neurodevelopmental outcome (Mehta & Paduch, 2012; Patwardhan et al., 2000; Samango-Sprouse et al., 2015) . Our current study adds further support for the potential effect of testosterone on verbal and perceptual reasoning, cognitive inhibition, and externalizing behaviors. Our findings suggest that some aspects of the neurodevelopmental disturbances of 47,XXY may be treatable by hormonal replacement, but further research is necessary on this relationship. Additionally, there may be a window of opportunity for optimal treatment, and additional study is warranted and underway on the optimal timing of hormonal treatment.
There is evidence that scores from the CBCL Internalizing scale may have the ability to discriminate between children with and without anxiety disorder (Seligman, Ollendick, Langley, & Baldacci, 2004) .
Behavioral dysfunction, such as anxiety disorders, low levels of testosterone, and high levels of estradiol, have been characterized in the phenotypic profile of 47,XXY as far back as the 1970's (Caldwell & Smith, 1972; Money, Annecillo, Orman, & Borgaonkar, 1974) . In our study, prenatal diagnosis was the only significant predictor for decreased CBCL Internalizing problems, while testosterone was the only significant predictor for decreased CBCL Externalizing problems.
Although this study did not find a relationship between testosterone and internalizing behavior problems, previous studies have shown a decrease in anxiety when boys with 47,XXY were treated with androgens during infancy, and between 6 and 12 years of age (Ross et al., 2017; . More in-depth studies are warranted to further understand this interaction and relationship with hormonal production.
Results on the ANT assessment further expose the selective variability within the neurocognitive function associated with 47,XXY.
Although individual variability was wide, the distribution was similar between the two international samples. Of note, the ANT subtest that showed significant group differences was Attention Regulation (p = .001), which was also the subtest that displayed the most variance due to external variables (Timing of Diagnosis and Testosterone by testosterone treatment, parental education, or timing of diagnosis in either cohort. Given that 47,XXY boys are known to be at high risk for neurodevelopmental disturbances and executive dysfunction, comprehensive screening is warranted at specific times to identify and treat any neurodevelopmental dysfunction.
In our study, significant differences between samples in internal- Limitations of the study may include different recruitment methods for NL and US participants and diverse care approaches in the two countries. Additionally, this study is inherently predisposed to ascertainment bias, as children who are referred to these centers for care may not be representative of the entire 47,XXY population, of which 75% never get diagnosed (Abramsky & Chapple, 1997; Bojesen et al., 2003) .
| CONCLUSION
Our prospective study revealed that several external factors may play a significant role in understanding variability and penetrance in cognitive and behavioral outcome in 47,XXY, both within and across samples. 
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